What is the next earnings date for BU stock?
BURCON NUTRASCIENCE CORP (BU.CA) will report earnings on 2026-06-22, after the market close.
TSX:BU • CA1208313009
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BURCON NUTRASCIENCE CORP (BU.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-29 | Canaccord Capital | Downgrade | Speculative Buy |
| 2021-11-17 | CanaccordFinancial | Downgrade | Buy |
| 2021-02-18 | Canaccord Genuity | Upgrade | |
| 2021-02-10 | Canaccord Genuity | Upgrade |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 360K 111.76% | 184.4K -48.78% | 381.4K 106.83% | 3.296M 764.18% | 14.42M 337.50% | |
| EBITDA YoY % growth | -7.28M -1.11% | -6.318M 13.21% | -6.323M -0.08% | -6.489M -2.62% | 3.605M 155.56% | |
| EBIT YoY % growth | -7.52M -2.17% | -7.019M 6.66% | -7.158M -1.97% | -6.489M 9.34% | 3.605M 155.56% | |
| Operating Margin | -2,088.89% | -3,806.40% | -1,876.66% | -196.88% | 25.00% | |
| EPS YoY % growth | N/A 91.94% | -0.05 47.18% | -0.77 -1,323.48% | -0.07 90.69% | 0.03 142.86% |
All data in CAD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 100.00% | 0.00 100.00% | 0.07 125.75% | 0.10 136.79% | 0.15 |
| Revenue Q2Q % growth | 1.545M 3,493.02% | 2.472M 622.81% | 3.296M 822.76% | 3.811M 415.63% | 4.841M 213.33% |
| EBITDA Q2Q % growth | -309K 66.64% | 206K 115.23% | 721K 154.75% | 1.03M 1,489.51% | 1.751M 666.67% |
| EBIT Q2Q % growth | -309K 82.45% | 206K 111.05% | 721K 128.73% | 1.03M 181.71% | 1.751M 666.67% |
All data in CAD
BURCON NUTRASCIENCE CORP (BU.CA) will report earnings on 2026-06-22, after the market close.
The consensus EPS estimate for the next earnings of BURCON NUTRASCIENCE CORP (BU.CA) is 0 CAD and the consensus revenue estimate is 1.54M CAD.